ALT
Altimmune Q4 FY25 Earnings Results
Financial Performance and Liquidity Altimmune reported a net loss of $27.4 million, or $0.27 per share, for the fourth quarter…
Altimmune, inc (ALT) Q2 2021 Earnings Conference Call
Altimmune, inc (NASDAQ: ALT) Q2 2021 Earnings Conference
Altimmune, inc (ALT) Altimmune To Announce First Quarter 2021 Financial Results On May 17, 2021
Altimmune, inc (NASDAQ: ALT) Q1 2021 Earnings Conference
